RBM15 targeted the N6-adenylate methylation (m6A) modification of TNFSF9, and overexpression of TNFSF9 could reverse the tumor-suppressing effect of silencing RBM15 on PTX-resistant TNBC cells in vitro and transplanted tumors in vivo. This evidence concerns the gene TNFSF9 and neoplasm.